This on-demand webinar examines the challenges and opportunities for manufacturers and payers in implementing an indication-specific pricing strategy.
With the development of innovative products across multiple indications, and the potential offered by combination approaches, challenges for pricing strategy are increasingly coming to the forefront.
Without alternative approaches to pricing, there are risks of delays or even failure to commercialize some indications at all. This is a concern for payers as well as manufacturers, as it reduces patient access to innovative treatments. Indication-specific pricing is a potential solution to this problem.
- Understand how indication-specific pricing can potentially overcome challenges for commercialization of products offering different value in different indications
- Appreciate the complexities that combination therapies present for pricing and reimbursement
- Gain insights for developing a value proposition for indication-specific pricing.